It has also been demonstrated that CSC targeting with ALDH1A1-specific CD8+ T cells is followed by decreased spontaneous metastatic burden of HNSCC, pancreatic, and breast cancer cells in vivo [116]. This evidence concerns the gene ALDH1A1 and breast cancer.